›› 2009, Vol. 4 ›› Issue (04): 342-348.

• 综述 • 上一篇    

干细胞疗法治疗缺血性卒中的研究进展

刘静华,曹亦宾,马建国   

  1. 063000 河北省唐山市唐山工人医院神经内科
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2009-04-20 发布日期:2009-04-20
  • 通讯作者: 曹亦宾

Research Status in Stem Cell Therapy for cerebral Infarction

  • Received:1900-01-01 Revised:1900-01-01 Online:2009-04-20 Published:2009-04-20

摘要: 目前缺血性卒中所致神经损伤修复的传统治疗方法尚无突破,而以干细胞为基础的新型治疗策略正成为研究热点。大量动物实验和部分临床实验已经证实,无论是机体自身干、祖细胞的动员、募集,还是自体或异体干细胞移植,都显著改善了受损的神经功能。目前已证实局部植入、静脉注入、或全身动员的干细胞在基质细胞衍生因子-1/基质细胞衍生因子-1受体4(Stromal cell-derived Factor-1/CXC Chemokine Receptor-4,SDF-1/CXCR4)趋化分子和β2-整联蛋白等因子的作用下归巢至脑缺血区域;提供富含营养因子的微环境,保护坏死灶周围缺血半暗带组织;增强血管发生和血管生成;促进卒中后内源性干、祖细胞的迁移、存活和分化;并逐渐分化为神经细胞替代丢失的神经元。这几重因素可能共同参与了结构重建和功能修复。

关键词: 干细胞; 脑梗死; 移植

Abstract: There is no existing effective treatment to repair neurological damage caused by ischemic stroke. Recent studies have highlighted a novel stem cell-based therapeutic approach for the treatment of ischemic stroke. A number of experiments in animal stroke models and a small number of clinical trials have demonstrated that mobilized and recruited endogenous or implanted exogenous stem cells improve neurological outcomes after stroke. Increasing evidence suggests that stem cells implanted locally or intravenously, or mobilized systemically, could migrate and home into ischemic region under the effects of stromal cell-derived factor-1/CXC chemokine receptor-4 (SDF-1/CXCR4)and β2-intergrin. The mechanism that the stem cell therapy might improve neurological deficits after stroke remain uncertain. Transplanted stem cells may provide a microenvironment with rich trophic factors for the ischemic penumbra surrounding the infarcted area, enhance angiogenesis and vasculogenesis, promote survival, migration, and differentiation of the endogenous stem/precursor cells after stroke, and differentiate into neurons to replace lost neurons.

Key words: Stem cells; Ischemic infarction; Transplantation